Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$38.4M
+755.1% from 2023
Prescriptions
53K
$727.56 per claim
Patients
14K
12,623 prescribers
Total spending, 2024
$38.4M
$2,784.13 per patient
Medicare prescription drug plans paid $38.4M for Veozah in 2024, for 52,780 prescriptions and refills to 13,794 patients (up 755.1% from 2023). The average cost per claim was $727.56.
California had the highest Medicare cost for Veozah in 2024: $3.2M for 4,066 claims, followed by New York ($2.5M).
Jamie E McKenzie, medical oncology in Tampa, FL, had the highest Medicare cost for Veozah in 2024: 53 claims costing $57K.
Veozah is made by Astellas Pharma Inc. (4503.T), listed in the Medicare spending data as Astellas Pharma.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jamie E McKenzie Tampa, FL | Medical Oncology | 53 | 17 | $57K |
| Maira P Campos Santa Barbara, CA | Hematology-Oncology | 39 | 12 | $34K |
| Matvey Brokhin Brooklyn, NY |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 2,707 | 5,863 | 2,835 | $4.5M |
| 2024 | 12,623 | 52,780 | 13,794 | $38.4M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Endocrinology |
| 55 |
| Under 11 |
| $33K |
| Wen Shen Baltimore, MD | Obstetrics & Gynecology | 24 | Under 11 | $32K |
| Lara Theobald Oklahoma City, OK | Medical Oncology | 46 | Under 11 | $25K |
| Yvonne L Fenrich North Bend, OR | Nurse Practitioner | 35 | Under 11 | $25K |
| Elaine Eustis Mt. Pleasant, SC | Obstetrics & Gynecology | 32 | Under 11 | $25K |
| Paige N Acham Boca Raton, FL | Nurse Practitioner | 42 | Under 11 | $24K |
| Marie L Bonvicino Toms River, NJ | Obstetrics & Gynecology | 18 | Under 11 | $22K |
| Heather Previs Stratford, CT | Nurse Practitioner | 27 | Under 11 | $22K |
| John Kaczmarek Waterbury, CT | Obstetrics & Gynecology | 22 | Under 11 | $21K |
| Makeba Williams Saint Louis, MO | Obstetrics & Gynecology | 22 | Under 11 | $21K |
| Andrea K Galloway The Villages, FL | Obstetrics & Gynecology | 39 | Under 11 | $21K |
| Luke M Wicke Joplin, MO | Family Practice | 16 | Under 11 | $21K |
| Najmuddin K Karimjee Houston, TX | Internal Medicine | 26 | Under 11 | $20K |
| Allison Walker Nashville, TN | Nurse Practitioner | 36 | Under 11 | $20K |
| Lakshmikanth Katragadda Huntsville, AL | Hematology-Oncology | 31 | Under 11 | $20K |
| Molly M Torvinen Sparks, NV | Family Practice | 19 | Under 11 | $20K |
| Martha C Combs-Woolum Pineville, KY | Internal Medicine | 23 | Under 11 | $20K |
| Sindhu Nair Sugar Land, TX | Medical Oncology | 31 | Under 11 | $20K |
| David M Furlong San Diego, CA | Obstetrics & Gynecology | 16 | Under 11 | $19K |
| Michael K Rowe Mount Vernon, KY | Family Practice | 23 | Under 11 | $19K |
| Diane J Sutter Kenmore, NY | Obstetrics & Gynecology | 32 | Under 11 | $19K |
| Robert B Hartmann Dover, DE | Obstetrics & Gynecology | 28 | Under 11 | $19K |
| Manpreet K Sidhu Elkton, MD | Hematology-Oncology | 25 | Under 11 | $19K |
| Spending |
|---|
| Astellas Pharma 4503.T | 52,827 | $38.4M |